AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PDS Biotechnology Corp Director's Dealing 2016

Jun 23, 2016

Director's Dealing

Opens in your device viewer

Issuer: Edge Therapeutics, Inc. (EDGE)
CIK: 0001472091
Period of Report: 2016-06-21

Reporting Person: Conti Kurt G (Director)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-21	Stock Option (right To Purchase)	$9.34	A	15000	Acquired	2026-06-21	Common Stock (15000)	Direct